Invention Grant
- Patent Title: Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia
-
Application No.: US16950574Application Date: 2020-11-17
-
Publication No.: US11077053B2Publication Date: 2021-08-03
- Inventor: Mohammed Dibas , Daniel W. Gil , Wayne Chen , Miguel Alcantara
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61P27/02 ; A61P27/10 ; A61K31/4178
Abstract:
Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
Public/Granted literature
- US20210059930A1 USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION Public/Granted day:2021-03-04
Information query
